James F. McDonough
Of Counsel
732-568-8360 jmcdonough@sh-law.comFirm Insights
Report Shows How Much Walgreens Stands To Gain with Inversion
Author: James F. McDonough
Date: June 18, 2014
Key Contacts
Back
Walgreens is just one of many U.S. companies to consider lowering its tax bill by moving abroad. This move, called an “inversion,” involves purchasing a foreign company and using it to alter the corporate structure so that the U.S. company is technically a corporate resident of the low-tax foreign country.
Walgreens has been considering the move since April, under pressure from shareholders such as Stefano Pessina, who is Walgreens’ largest shareholder and the executive chairman of Alliance Boots, the company with which it would merge, according to a new report from Americans for Tax Fairness.
A Walgreens inversion would cost the U.S. more than $4 billion over the course of five years in lost tax revenue, the report found. At the same time, the company would continue to receive significant benefit from U.S. taxpayers. Approximately $16.7 billion of Walgreens’ $72 billion in 2013 sales came from Medicare and Medicaid, government-funded healthcare programs.
The report also makes the argument that an inversion might give Walgreens an unfair advantage. Between 2008 and 2012, Walgreens paid a U.S. tax rate of 31 percent – close to the official tax rate of 35 percent. During the same period, competitor CVS Caremark paid an effective tax rate of 34 percent, and is currently not making an effort to move offshore. If Walgreens were to complete an inversion, its tax rate would sink to about 20 percent, which could give it an unfair advantage over competitors, or force them to make the same move.
Some shareholders oppose the move, including CtW Investment Group, which owns less than 1 percent of the company’s shares, according to The New York Times. The group sent a letter to Walgreens’ management explaining its position, citing possible removal from the S&P 500, diminished shareholder protections in Switzerland and reputational risks as reasons not to carry out the inversion.
If you have any questions about this post or would like to discuss your company’s tax,trust, and estate matters , please contact me, James F. McDonough at ScarinciHollenbeck.com.
- Practices: Corporate Tax Planning, Tax and Trusts & Estates, International Law & Trade, Sophisticated Estate Planning & Wealth Preservation
- Locations: Red Bank, NJ, New York City, Little Falls, NJ
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Related Posts
See all
New Jersey’s Next Manufacturing Tax Credit: Stability Secured, Timing Matters
A Settled Regulatory Environment Enables Confident Capital Planning New Jersey’s new manufacturing incentive program, Next New Jersey Manufacturing Program, enters 2026 with something uncommon in economic development these days: policy stability. The statute is enacted, New Jersey Economic Development Authority’s (“NJEDA”) rules are adopted, and the application portal is open. With the election outcome settled, […]
Author: Michael J. Sheppeard
A Simple Guide to Industry Roll-Up Acquisitions
When done successfully, industry roll-up acquisitions can dramatically grow and strengthen your business. In this post, we break down what an industry roll-up is, why companies pursue it, and what makes it an effective (and sometimes risky) business strategy. What Is an Industry Roll-Up Acquisition? In an industry roll-up acquisition of companies, a buyer acquires multiple companies […]
Author: Dan Brecher
Genesis Mission: How the U.S. Government’s New AI Platform Will Reshape Corporate Innovation, Risk, and Competition
The federal government has launched one of the most ambitious scientific initiatives in decades, and it will redefine how companies develop technology, manage risk, and compete. The Genesis Mission, created by Executive Order and driven by the Department of Energy (“DOE”), is intended to accelerate scientific discovery through a national AI platform that links supercomputers, […]
Author: Michael J. Sheppeard
Stablecoins and the GENIUS Act: How New Global Rules Are Reshaping Compliance
Stablecoins Leave the Grey Zone Stablecoins were supposed to be the “boring” part of crypto: digital dollars that just work. Yet for years they have lived in a regulatory no-man’s-land, classified one day as securities, the next as commodities, and sometimes as something regulators had not even named yet. That uncertainty is finally starting to […]
Author: Bryce S. Robins
Don’t Overlook the Importance of Business License Management
If you operate a business without the proper license, you risk fines, insurance issues, reputational harm, and even business closure. Even innocent mistakes, like forgetting to renew a license, can have significant consequences, such as losing your lawsuit for payment of services that are unlicensed, which makes it imperative to have business license management procedures […]
Author: Dan Brecher
Failing to Comply With NJ Rent Control Exemption May Prove Costly
What Developers Need to Know About New Jersey’s Rent Control Exemption Law to Ensure Entitlement to Exemption for Newly Constructed Multi-family Housing. A property owner in Jersey City is facing a $400 million federal class action lawsuit alleging that the landlord did not follow the procedural steps required to be eligible for exemption from local […]
Author: Patrick T. Conlon
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.